Oncology

REACH is an experienced thought leader in the oncology space. Our team has conducted research across many oncological diseases, both rare and non-rare.

DISEASES WE COVER

Oncology has evolved from brute force chemotherapy to the use of increasingly targeted precision medicine approaches. Current oncology dynamics the REACH team is tracking include:

  • The rise of antibody-drug conjugates (ADCs) and radiopharmaceuticals to improve selectivity of longstanding chemotherapy and radiation approaches and reduce off-target effects
  • Next generation of immunotherapy treatment including allogenic CAR T, CAR T for solid tumors and bispecifics
  • Precision approaches to improve treatment selection and response monitoring
See our rare oncology solutions

Search Oncology diseases we cover

Disease
Breast Cancer
Breast Cancer
Cancer Cachexia
Cancer Cachexia
Cholangiocarcinoma
Cholangiocarcinoma
Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Glioblastoma / Glioma
Glioblastoma / Glioma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome
Myelodysplastic Syndrome
Myelofibrosis
Myelofibrosis
Neuroendocrine Tumors
Neuroendocrine Tumors
Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Pancreatic Cancer
Polycythemia Vera
Polycythemia Vera
Renal Cell Carcinoma
Renal Cell Carcinoma
Waldenstrom Macroglobulinemia
Waldenstrom Macroglobulinemia
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Breast Cancer
Breast Cancer
Cancer Cachexia
Cancer Cachexia
Cholangiocarcinoma
Cholangiocarcinoma
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2 3 … 5

Schedule an oncology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare oncology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare oncological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any oncology disease allow easy comparison across the oncology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for oncologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us